Literature DB >> 20887205

AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection: a therapeutic dilemma in resource‐limited settings.

Thuy Le1, Tran Thi Hong Chau, Ngo Thi Kim Cuc, Pham Si Lam, Tran Phu Manh Sieu, Cecilia M Shikuma, Jeremy N Day.   

Abstract

AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection has not been adequately studied and poses unique therapeutic challenges in resource‐limited settings. Itraconazole poorly penetrates the central nervous system, whereas fluconazole has poor activity against P. marneffei. We prospectively report management of 1 patient and retrospectively review 7 coinfection cases from Vietnam.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20887205     DOI： 10.1086/656685

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  6 in total

1.  AIDS-associated Penicillium marneffei infection of the central nervous system.

Authors:  Thuy Le; Nguyen Huu Chi; Ngo T Kim Cuc; Tran Phu Manh Sieu; Cecilia M Shikuma; Jeremy Farrar; Jeremy N Day
Journal:  Clin Infect Dis       Date:  2010-11-05       Impact factor: 9.079

2.  Aetiologies of central nervous system infection in Viet Nam: a prospective provincial hospital-based descriptive surveillance study.

Authors:  Nghia Ho Dang Trung; Tu Le Thi Phuong; Marcel Wolbers; Hoang Nguyen Van Minh; Vinh Nguyen Thanh; Minh Pham Van; Nga Tran Vu Thieu; Tan Le Van; Diep To Song; Phuong Le Thi; Thao Nguyen Thi Phuong; Cong Bui Van; Vu Tang; Tuan Hoang Ngoc Anh; Dong Nguyen; Tien Phan Trung; Lien Nguyen Thi Nam; Hao Tran Kiem; Tam Nguyen Thi Thanh; James Campbell; Maxine Caws; Jeremy Day; Menno D de Jong; Chau Nguyen Van Vinh; H Rogier Van Doorn; Hien Tran Tinh; Jeremy Farrar; Constance Schultsz
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

3.  Innate Immunity Acts as the Major Regulator in Talaromyces marneffei Coinfected AIDS Patients: Cytokine Profile Surveillance During Initial 6-Month Antifungal Therapy.

Authors:  Rong-Jing Dong; Yun-Gui Zhang; Lei Zhu; Heng-Li Liu; Jun Liu; Yi-Qun Kuang; Rui-Rui Wang; Yu-Ye Li
Journal:  Open Forum Infect Dis       Date:  2019-04-26       Impact factor: 3.835

4.  Concurrent infection with Talaromyces marneffei and Cryptococcus neoformans in a patient without HIV infection.

Authors:  Susu He; Dongqing Lv; Youzu Xu; Xiaomai Wu; Ling Lin
Journal:  Exp Ther Med       Date:  2019-11-07       Impact factor: 2.447

5.  An inexpensive point-of-care immunochromatographic test for Talaromyces marneffei infection based on the yeast phase specific monoclonal antibody 4D1 and Galanthus nivalis agglutinin.

Authors:  Kritsada Pruksaphon; Akarin Intaramat; Pavinee Simsiriwong; Skorn Mongkolsuk; Kavi Ratanabanangkoon; Joshua D Nosanchuk; Anna Kaltsas; Sirida Youngchim
Journal:  PLoS Negl Trop Dis       Date:  2021-05-04

6.  Successful Management of Mixed Mycosis in HIV-Negative Patients With Different Immune Status: A Case Series Report.

Authors:  Yangqing Zhan; Chun Lu; Shaoqiang Li; Jin Zhao; Zhengtu Li; Yingying Gu; Feng Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-03-04       Impact factor: 5.293
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.